Search Results

Showing results 9891 - 9900 for 2023?

Anticoagulation in COVID-19: Effect of Enoxaparin, Heparin, and Apixaban on Mortality. | Pathology & Laboratory Medicine

...2016 Resident Research Day 2015 Resident Research Day 2014 Pathology Trainee Research Day - May 10, 2023...

https://pathology.weill.cornell.edu/research/publications/anticoagulation-covid-19-effect-enoxaparin-heparin-and-apixaban-mortality

Correlation of Coagulation Parameters With Clinical Outcomes During the Coronavirus-19 Surge in New York: Observational Cohort. | Pathology & Laboratory Medicine

...2016 Resident Research Day 2015 Resident Research Day 2014 Pathology Trainee Research Day - May 10, 2023...

https://pathology.weill.cornell.edu/research/publications/correlation-coagulation-parameters-clinical-outcomes-during-coronavirus-19

Methionine metabolism controls the B cell EBV epigenome and viral latency. | Roth Lab

...Submitted by gca4001 on February 22, 2023 - 2:26pm Title Methionine metabolism controls the B cell EBV...

https://rothlab.weill.cornell.edu/publications/methionine-metabolism-controls-b-cell-ebv-epigenome-and-viral-latency

Combined EZH2 and Bcl-2 inhibitors as precision therapy for genetically defined DLBCL subtypes. | Roth Lab

...Submitted by gca4001 on February 22, 2023 - 2:23pm Title Combined EZH2 and Bcl-2 inhibitors as precision...

https://rothlab.weill.cornell.edu/publications/combined-ezh2-and-bcl-2-inhibitors-precision-therapy-genetically-defined-dlbcl-subtypes

Epigenetic reprogramming sensitizes immunologically silent EBV+ lymphomas to virus-directed immunotherapy. | Roth Lab

...Submitted by gca4001 on February 22, 2023 - 2:22pm Title Epigenetic reprogramming sensitizes immunologically...

https://rothlab.weill.cornell.edu/publications/epigenetic-reprogramming-sensitizes-immunologically-silent-ebv-lymphomas-virus-directed

Otolaryngologist and pediatric oncologist perspectives on the role of fine needle aspiration in diagnosing pediatric head and neck masses. | Roth Lab

...Submitted by gca4001 on February 22, 2023 - 2:18pm Title Otolaryngologist and pediatric oncologist perspectives...

https://rothlab.weill.cornell.edu/publications/otolaryngologist-and-pediatric-oncologist-perspectives-role-fine-needle-aspiration

Ibrutinib significantly inhibited Bruton's tyrosine kinase (BTK) phosphorylation,in-vitro proliferation and enhanced overall survival in a preclinical Burkitt lymphoma (BL) model. | Roth Lab

...Submitted by gca4001 on February 22, 2023 - 2:17pm Title Ibrutinib significantly inhibited Bruton's tyrosine...

https://rothlab.weill.cornell.edu/publications/ibrutinib-significantly-inhibited-brutons-tyrosine-kinase-btk-phosphorylationin-vitro

Outcome of children and adolescents with relapsed Hodgkin lymphoma treated with high-dose therapy and autologous stem cell transplantation: the Memorial Sloan Kettering Cancer Center experience. | Roth Lab

...Submitted by gca4001 on February 22, 2023 - 2:13pm Title Outcome of children and adolescents with relapsed...

https://rothlab.weill.cornell.edu/publications/outcome-children-and-adolescents-relapsed-hodgkin-lymphoma-treated-high-dose-therapy

Flow sorting and exome sequencing reveal the oncogenome of primary Hodgkin and Reed-Sternberg cells. | Roth Lab

...Submitted by gca4001 on February 22, 2023 - 2:09pm Title Flow sorting and exome sequencing reveal the...

https://rothlab.weill.cornell.edu/publications/flow-sorting-and-exome-sequencing-reveal-oncogenome-primary-hodgkin-and-reed-sternberg

Rituximab pharmacokinetics in children and adolescents with de novo intermediate and advanced mature B-cell lymphoma/leukaemia: a Children's Oncology Group report. | Roth Lab

...Submitted by gca4001 on February 22, 2023 - 2:08pm Title Rituximab pharmacokinetics in children and adolescents...

https://rothlab.weill.cornell.edu/publications/rituximab-pharmacokinetics-children-and-adolescents-de-novo-intermediate-and-advanced

Showing results 9891 - 9900 for 2023?